March 26, 2020 / 10:47 PM / 9 days ago

BRIEF-Phio Pharmaceuticals Reports Year End 2019 Financial Results And Provides Business Update

March 26 (Reuters) - Phio Pharmaceuticals Corp:

* PHIO PHARMACEUTICALS REPORTS YEAR END 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* PHIO PHARMACEUTICALS CORP - AT DECEMBER 31, 2019, COMPANY HAD CASH OF $6.9 MILLION

* PHIO PHARMACEUTICALS - EXPECTS ITS CASH WILL BE SUFFICIENT TO FUND CURRENTLY PLANNED OPERATIONS FOR AT LEAST NEXT 12 MONTHS

* PHIO PHARMACEUTICALS - EXPECTS THAT PH-762 CAN BE READY TO ENTER THE CLINIC WITH A PARTNER IN ACT THERAPY IN THE SECOND HALF OF 2020

* PHIO PHARMACEUTICALS - EXPECTS THAT PH-762 CAN BE READY FOR DIRECT THERAPEUTIC USE TOWARDS TME THROUGH INTRA-TUMORAL INJECTION IN 2021

* PHIO PHARMACEUTICALS QTRLY LOSS PER SHARE OF $4.69 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below